Nuform offers sermorelin and weight-care prescriptions through the same broader telehealth service. That can make the menu feel like a ready-made combined plan. The first useful question is simpler: what exactly is being prescribed, why is each treatment proposed, and what evidence supports each part for your goal?
We checked Nuform’s public product pages, care-model description and refund policy on October 16, 2026. This is a source review, not an enrollment, a pharmacy test or a report of patient results. We keep the company’s descriptions of its team and products separate from independently established treatment benefits.
A shared care team can coordinate questions; it cannot turn two product menus into evidence for a combination.
Begin with the two product records
The sermorelin page and weight-care page describe different offerings. The latter uses GLP vitamin-blend and GLP+GIP vitamin-blend labels, while the former markets sermorelin kits. Those categories should not become one vague peptide purchase in your notes.
Ask for the actual prescription names, ingredients, quantities and dispensing pharmacy. A menu label is not a complete dispensing label, and an offer appearing beside another does not establish that both will be prescribed. The combination-evidence guide explains why each proposed addition needs its own clinical purpose.
Read the kit total before the monthly equivalent
The rendered sermorelin page displayed a $350 two-month kit and a $650 four-month kit. The larger kit’s displayed monthly headline was $160, while dividing its stated total by four gives $162.50. We retain the stated total rather than treating the rounded headline as an exact recurring charge.
The weight page separately displayed a $389 three-month GLP starter kit and a $499 two-and-a-half-month GLP+GIP starter kit, with other maintenance options. These are examples of different purchase periods, not interchangeable treatment quotes. Confirm what is charged now, what later payments are required and what happens if the clinical plan changes during the kit period.
Confirm care and laboratory charges separately
The care-model page needs a careful reading. Its extracted text contains a $170 annual physician fee and laboratory pricing from $95, but those amounts were not visible on the rendered page in our October 16 recheck. We do not treat them as a confirmed current quote. Ask for a written total identifying clinical access, testing and medication separately.
The extracted FAQ also distinguishes laboratory requirements for hormone or peptide care from the GLP-1 route. Confirm the current process for the actual proposed treatment; a website statement is not an individual recommendation to skip testing. Ask who orders and reviews any tests and whether care charges apply per treatment or across the proposed plan.
A check-in promise still needs a practical definition
Nuform describes an assigned provider and specialist, direct phone and text access, and proactive contact every four weeks. These are useful service features to ask about. We did not test whether the same staff remain assigned, how quickly messages are answered or what a particular check-in includes.
Clarify which person can make prescribing decisions and how a new concern reaches that clinician. Ask who reviews information from another prescriber and what happens when an in-person assessment is needed. Use the first-appointment guide to bring a complete list of prescriptions and supplements rather than assuming separate care teams share records automatically.
Compounding is not finished-product approval
Nuform describes medicines supplied through licensed U.S. compounding pharmacies. That sourcing description does not make a compounded preparation FDA-approved. FDA explains that it does not review compounded drugs for safety, effectiveness and quality before marketing.
Ask about the exact product and pharmacy rather than using terms such as pharmaceutical grade as a substitute for the record. An approved medicine’s trial, a pharmacy designation or research on one ingredient cannot establish the outcome of every compounded formulation. Our approval-status guide keeps historical products and current compounded offerings distinct.
A body-composition claim needs combination-specific evidence
The sermorelin page markets benefits relating to muscle, recovery and fat loss. We treat those as provider claims. The reviewed product pages do not themselves establish a controlled result for adding the selected sermorelin preparation to a particular GLP-1 treatment, in a patient group matching you.
Ask which study supports the proposed addition, what the comparator received and whether the outcome was measured muscle, strength, function or simply body weight. A testimonial cannot isolate the effects of two medicines, nutrition changes and exercise occurring together. This review supplies no combination schedule and makes no finding that the pairing is safe or necessary.
Read refunds by service type before paying
The refund policy visibly treats medication orders as final at purchase, says pharmacy orders cannot be refunded and dispensed medicines cannot be returned, and distinguishes laboratory services before and after completion. Completed bloodwork is nonrefundable under the displayed policy.
Extracted page text also contains physician-fee provisions that were not visible in the rendered policy at our October 16 recheck. We therefore do not promise a consultation-fee or non-approval refund. Ask which written policy governs every charge before paying. An unshipped kit or an unsatisfactory result does not itself establish a refund right.
No monthly subscription does not mean no future decision
The rendered care-model page says patients can stop by choosing not to reorder a kit. That is a description of future medication purchases, not a confirmed answer about every possible care charge, an already purchased kit or the timing of clinical reassessment. Ask for the selected plan’s renewal terms in writing.
The product pages also use billing-period wording that needs to be read with the actual order. Our cost guide helps compare full payments over a common period. Avoid combining a kit total, an unconfirmed fee and different supply periods into an artificially favorable monthly number.
Our assessment: useful disclosures, questions still open
Nuform publishes enough information to begin a concrete conversation about care access, kit totals and exit terms. Its menu remains a starting point. We have not verified the selected pharmacy, the final formula, individual eligibility, fulfillment time or clinical outcomes, and the review does not award a medical-performance score.
A useful next step is a written plan that identifies each treatment, its purpose, the evidence for adding it, all charges and the review date. If the case for an extra medicine remains unclear, ask the clinician to explain alternatives, including not adding it. The question planner can keep that discussion focused on the decisions that matter to you.
Follow the sources.
Provider pages establish advertised terms, not independently measured outcomes. General medical guidance does not validate every compounded preparation.
- Nuform: sermorelin therapy (opens in a new tab)
Current rendered product menu and kit totals; provider claims, not independent clinical findings. Checked October 16, 2026.
- Nuform: weight-loss offerings (opens in a new tab)
Current rendered GLP vitamin-blend and GLP+GIP kit descriptions. The selected prescription and payment schedule require confirmation. Checked October 16, 2026.
- Nuform: care model and charges to confirm (opens in a new tab)
Rendered care model checked October 16, 2026. Extracted fee and laboratory-price text was not visible in the rendered page and is not a confirmed current quote.
- FDA: Understanding the Risks of Compounded Drugs (opens in a new tab)
Compounded preparations are not FDA-approved and do not undergo the agency’s premarket review. Checked October 15, 2026.
- Nuform: refund policy (opens in a new tab)
Rendered medication and laboratory refund rules checked October 16, 2026. Extracted physician-fee clauses were not visible and are not presented as a confirmed refund promise.
